Viridian Therapeutics, Inc.DE (VRDN)

Every official Viridian Therapeutics, Inc.DE filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Viridian Therapeutics, Inc.DE documents

• Viridian Therapeutics, Inc.DE 10-K 2026VRDN 10-K 2026: annual report for fiscal 2026
• Viridian Therapeutics, Inc.DE 10-K 2025VRDN 10-K 2025: annual report for fiscal 2025
• Viridian Therapeutics, Inc.DE 10-K 2024VRDN 10-K 2024: annual report for fiscal 2024
• Viridian Therapeutics, Inc.DE 10-K 2023VRDN 10-K 2023: annual report for fiscal 2023
• Viridian Therapeutics, Inc.DE 10-K 2022VRDN 10-K 2022: annual report for fiscal 2022
• Viridian Therapeutics, Inc.DE 10-Q 2026VRDN 10-Q 2026: quarterly report for fiscal 2026
• Viridian Therapeutics, Inc.DE 10-Q 2025VRDN 10-Q 2025: quarterly report for fiscal 2025
• Viridian Therapeutics, Inc.DE 10-Q 2024VRDN 10-Q 2024: quarterly report for fiscal 2024
• Viridian Therapeutics, Inc.DE 10-Q 2023VRDN 10-Q 2023: quarterly report for fiscal 2023
• Viridian Therapeutics, Inc.DE 10-Q 2022VRDN 10-Q 2022: quarterly report for fiscal 2022
• Viridian Therapeutics, Inc.DE 8-K 2026VRDN 8-K 2026: current report for fiscal 2026
• Viridian Therapeutics, Inc.DE 8-K 2025VRDN 8-K 2025: current report for fiscal 2025
• Viridian Therapeutics, Inc.DE 8-K 2024VRDN 8-K 2024: current report for fiscal 2024
• Viridian Therapeutics, Inc.DE 8-K 2023VRDN 8-K 2023: current report for fiscal 2023
• Viridian Therapeutics, Inc.DE 8-K 2022VRDN 8-K 2022: current report for fiscal 2022
• Viridian Therapeutics, Inc.DE DEF 14A 2026VRDN DEF 14A 2026: proxy statement for fiscal 2026
• Viridian Therapeutics, Inc.DE DEF 14A 2025VRDN DEF 14A 2025: proxy statement for fiscal 2025
• Viridian Therapeutics, Inc.DE DEF 14A 2024VRDN DEF 14A 2024: proxy statement for fiscal 2024
• Viridian Therapeutics, Inc.DE DEF 14A 2023VRDN DEF 14A 2023: proxy statement for fiscal 2023
• Viridian Therapeutics, Inc.DE DEF 14A 2022VRDN DEF 14A 2022: proxy statement for fiscal 2022
• Viridian Therapeutics, Inc.DE Form 4 2026VRDN Form 4 2026: insider trading filing for fiscal 2026
• Viridian Therapeutics, Inc.DE Form 4 2025VRDN Form 4 2025: insider trading filing for fiscal 2025
• Viridian Therapeutics, Inc.DE Form 4 2024VRDN Form 4 2024: insider trading filing for fiscal 2024
• Viridian Therapeutics, Inc.DE Form 4 2023VRDN Form 4 2023: insider trading filing for fiscal 2023
• Viridian Therapeutics, Inc.DE Form 4 2022VRDN Form 4 2022: insider trading filing for fiscal 2022
• Viridian Therapeutics, Inc.DE S-1 2026VRDN S-1 2026: registration statement for fiscal 2026
• Viridian Therapeutics, Inc.DE S-1 2025VRDN S-1 2025: registration statement for fiscal 2025
• Viridian Therapeutics, Inc.DE S-1 2024VRDN S-1 2024: registration statement for fiscal 2024
• Viridian Therapeutics, Inc.DE S-1 2023VRDN S-1 2023: registration statement for fiscal 2023
• Viridian Therapeutics, Inc.DE S-1 2022VRDN S-1 2022: registration statement for fiscal 2022
• Viridian Therapeutics, Inc.DE 13F 2026VRDN 13F 2026: institutional holdings for fiscal 2026
• Viridian Therapeutics, Inc.DE 13F 2025VRDN 13F 2025: institutional holdings for fiscal 2025
• Viridian Therapeutics, Inc.DE 13F 2024VRDN 13F 2024: institutional holdings for fiscal 2024
• Viridian Therapeutics, Inc.DE 13F 2023VRDN 13F 2023: institutional holdings for fiscal 2023
• Viridian Therapeutics, Inc.DE 13F 2022VRDN 13F 2022: institutional holdings for fiscal 2022

More companies